Generation of diseased and isogenic control human induced pluripotent stem cell lines MHHi043-A & MHHi043-B from a female Fabry disease patient carrying c.644A > G missense mutation.
Aug 2026· Stem Cell Research· Vol 95, pp.
104084
· 0 citations· 2 references
Medicine
TL;DR
Two human induced pluripotent stem cell lines from a female FD patient carrying a heterozygous c.644A > G missense mutation provide a valuable resource for studying FD mechanisms and developing therapeutic strategies.
Abstract
Fabry disease (FD) is a monogenic, X-linked lysosomal storage disorder originating from mutations in the GLA gene, which encodes alpha-galactosidase A. Impaired enzyme activity leads to accumulation of the substrate globotriaosylceramide (Gb3) and a multisystemic phenotype. Here, we generated two human induced pluripotent stem cell (hiPSC) lines from a female FD patient carrying a heterozygous c.644A > G missense mutation. The hiPSCs displayed normal karyotype, typical morphology, trilineage differentiation capacity and expressed markers of undifferentiated hPSC state. Consequently, MHHi043-A and MHHi043-B provide a valuable resource for studying FD mechanisms and developing therapeutic strategies.
Fabry disease is a rare genetic disease caused by loss-of-function in the GLA gene. This gene encodes the lysosomal enzyme α-galactosidase A (α-Gal A). A deficiency of α-Gal A results in the globotriaosylceramide buildup throughout the major organs, which is associated with increased mortality from cardiac disease in p...
Debarun Patra, D. Cabrera, Xiaochun Yang et al.· Stem Cell Research· 0 citations
A human induced pluripotent stem cell line TRNDi045-A-38 from the KOLF2.1J reference line is generated, engineered to carry homozygous DOK7 c.1124_1127dupTGCC mutation knock-in using CRISPR/Cas9, and could be used for in vitro disease modeling to study disease pathophysiology and for therapeutic development.
B. M. Jones, Miao Xu, J. Zou et al.· Stem Cell Research· 0 citations
This work generated and characterized the induced isogenic pluripotency stem cell control line generated by correcting the c.1824C > T mutation and excluded differences in genetic background while studying the pathophysiology of HGPS.
G. Lezzoche, Evangelia Ntotsia, S. Seyen et al.· Stem Cell Research· 0 citations
Patient-derived induced pluripotent stem cells (hiPSC) are a valuable approach to model cardiovascular diseases and nucleofected non-integrating episomal vectors in skin fibroblasts of four family members are a reliable source to study the effect of the identified mutation in a physiologically relevant environment.
E. Selga, R. Martínez-Moreno, Albert Rigat Pujolàs et al.· Stem Cell Research· 0 citations
This patient-specific iPSC line provides a valuable resource for generating choroid plexus organoids and neurons to investigate disease mechanisms and develop therapeutic strategies to investigate disease mechanisms and develop therapeutic strategies.
Weronika Przybala, Swapnil Gupta, H. Fjerdingstad et al.· bioRxiv· 0 citations
These iPSC lines are valuable models to help investigate the pathomechanism of prolidase deficiency and are reprogrammed into induced pluripotent stem cell (iPSC) lines and additionally generated isogenic controls using CRISPR-Cas9 genome editing.
R. Suri, Kevin Emmerich, Sahana Manohar-Sindhu et al.· Stem Cell Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
